Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
11 Dec 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/reverse-reverse-liver-disease-biotech-hepion-and-pharma-two-b-call-merger
05 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/05/2992326/0/en/Pharma-Two-B-Announces-Poster-Presentation-on-P2B001-at-the-Annual-Meeting-of-the-Parkinson-s-Disease-Study-Group.html
11 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/11/2978264/0/en/Pharma-Two-B-and-Hepion-Pharmaceuticals-Inc-Announce-Effectiveness-of-Registration-Statement-Related-to-Proposed-Merger.html
04 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/04/2940630/0/en/Pharma-Two-B-and-Hepion-Pharmaceuticals-Inc-Announce-Filing-of-Registration-Statement-on-Form-F-4-Related-to-Proposed-Merger.html
15 Sep 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/09/15/2516777/0/en/Pharma-Two-B-Presents-Positive-Efficacy-and-Safety-Data-of-P2B001-from-Phase-3-Trial-at-the-MDS-International-Congress-of-Parkinson-s-Disease-and-Movement-Disorders.html
05 Apr 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/04/05/2416529/0/en/Pharma-Two-B-Presents-Late-Breaker-Abstract-on-Positive-Efficacy-and-Safety-Data-of-P2B001-from-Phase-3-Trial-at-American-Academy-of-Neurology-AAN-Annual-Meeting.html
ABOUT THIS PAGE